It is imperative to consider the meaning of leprosy and everyday experiences of people affected by leprosy and key persons in the community if one aims to make leprosy services more effective, which appears necessary in Indonesia given the large numbers of new cases detected annually. However, little is written in the international literature about the experiences of people currently being treated for leprosy, those cured, or other key informants. This paper analyses the narratives of the people by drawing upon in-depth interviews with 53 participants and 20 focus groups discussions. The participants were purposively selected. We provide insights into the experiences of people and the meaning they give to leprosy and highlight aspect of aetiology, spirituality, religion, darkening of the skin, and sorcery. We also examine experiences of seeking care and focused on the impact of the disease in particular on the elderly and children. In conclusion, the continued need for implementation of leprosy services in Indonesia is very evident. The diversities in people’s experiences with leprosy indicate a demand for responsive leprosy services to serve the diverse needs, including services for those formally declared to be “cured.” 1. Introduction Over the last decades, efforts in the field of leprosy have focused on curing the disease, controlling its spread, and preventing impairments. From a global perspective the results are impressive and commendable with a decline of the number of new cases and the reduction of the proportion with severe visual impairments at diagnosis [1]. For some countries, among others Indonesia, the picture is not yet so notable. Also for implications beyond the medical scope such as stigma, the road is still long [2–4]. Leprosy has been associated with stigma throughout history [5–9]. Manifestations of stigma, including self-stigma, social exclusion, and discrimination, although nowadays more subtle with less ostracism, remain a reality for many people affected [10]. To help leprosy services become more perceptive towards issues surrounding leprosy-related stigma and reduce its impact, it is necessary to understand stigma from the perspective of the people affected and their family members. Also the views of key persons in the community, such as neighbours, teachers, religious leaders, and health workers, should be considered. “The human face of leprosy” edited by Gokhale and Sohoni [11] in 1999 already emphasised the need for such stories. Several studies related to leprosy have been executed in Indonesia focussing on biomedical
B. Ebenso, A. Fashona, M. Ayuba, M. Idah, G. Adeyemi, and S. S-Fada, “Impact of socio-economic rehabilitation on leprosy stigma in northern Nigeria: findings of a retrospective study,” Asia Pacific Disability Rehabilitation Journal, vol. 18, no. 2, pp. 98–119, 2007.
[3]
S. A. M. Stevelink, W. H. van Brakel, and V. Augustine, “Stigma and social participation in Southern India: differences and commonalities among persons affected by leprosy and persons living with HIV/AIDS,” Psychology, Health & Medicine, vol. 16, no. 6, pp. 695–707, 2011.
[4]
B. H. Bennett, D. L. Parker, and M. Robson, “Leprosy: steps along the journey of eradication,” Public Health Reports, vol. 123, no. 2, pp. 198–205, 2008.
[5]
M. L. Heijnders, “The dynamics of stigma in leprosy,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 72, no. 4, pp. 437–447, 2004.
[6]
O. K. Skinsnes, “Leprosy in society III. The relationship of the social to the medical pathology of leprosy,” Leprosy Review, vol. 35, pp. 175–181, 1964.
[7]
J. Rafferty, “Curing the stigma of leprosy,” Leprosy Review, vol. 76, no. 2, pp. 119–126, 2005.
[8]
W. H. Jopling, “Leprosy stigma,” Leprosy Review, vol. 62, no. 1, pp. 1–12, 1991.
[9]
W. H. van Brakel, “Measuring leprosy stigma—a preliminary review of the leprosy literature,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 71, no. 3, pp. 190–197, 2003.
[10]
W. H. van Brakel, B. Sihombing, H. Djarir et al., “Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination,” Global Health Action, vol. 5, 2012.
[11]
S. D. Gokhale and N. Sohoni, Human Face of Leprosy, Ameya Prakashan, Pune, India, 1999.
[12]
M. Hatta, S. M. van Beers, B. Madjid, A. Djumadi, M. Y. L. de Wit, and P. R. Klatser, “Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 4, pp. 381–385, 1995.
[13]
M. Matsuoka, T. Budiawan, K. S. Aye et al., “The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines,” Leprosy Review, vol. 78, no. 4, pp. 343–352, 2007.
[14]
M. Hatta, M. Makino, Ratnawati et al., “Detection of serum antibodies to M. leprae major membrane protein-II in leprosy patients from Indonesia,” Leprosy Review, vol. 80, no. 4, pp. 402–409, 2009.
[15]
S. M. van Beers, M. Hatta, and P. R. Klatser, “Patient contact is the major determinant in incident leprosy: implications for future control,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 67, no. 2, pp. 119–128, 1999.
[16]
M. I. Bakker, M. Hatta, A. Kwenang et al., “Risk factors for developing leprosy—a population-based cohort study in Indonesia,” Leprosy Review, vol. 77, no. 1, pp. 48–61, 2006.
[17]
M. I. Bakker, L. May, M. Hatta et al., “Genetic, household and spatial clustering of leprosy on an island of Indonesia: a population-based study,” BMC Medical Genetics, vol. 6, article 40, 2005.
[18]
A. A. Louhenapessy and B. Zuiderhoek, “A practical method of active case finding and epidemiological assessment: its origin and application in the leprosy control project in Indonesia,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 65, no. 4, pp. 487–491, 1997.
[19]
P. A. M. Schreuder, D. S. Liben, S. Wahjuni, J. van den Broek, and R. De Soldenhoff, “A comparison of rapid village survey and leprosy elimination campaign, detection methods in two districts of East Java, Indonesia, 1997/1998 and 1999/2000,” Leprosy Review, vol. 73, no. 4, pp. 366–375, 2002.
[20]
C. M. Varkevisser, P. Lever, O. Alubo et al., “Gender and leprosy: case studies in Indonesia, Nigeria, Nepal and Brazil,” Leprosy Review, vol. 80, no. 1, pp. 65–76, 2009.
[21]
District Health Office Cirebon, Annual Leprosy Statistics Cirebon 2011, 2012.
[22]
Ministry of Health Indonesia, Annual Leprosy Statistics Indonesia 2011, 2012.
[23]
M. Susila, “Public health development in Indonesia,” in Public Health Progress in the Pacific: Geographical Background and Regional Development, J. A. R. Miles, Ed., pp. 5–24, Dr. Wolf Tietze GeoWissenschaftliche GmbH, Helmstedt, Germany, 1984.
[24]
Y. Hasibuan, “Leprosy elimination campaign Indonesia,” in Human Face of Leprosy, S. D. Gokhale and N. Sohoni, Eds., p. 67, Ameya Prakashan, Pune, India, 1999.
[25]
Ministry of Health Indonesia, National Leprosy Control Programme, Sudit Kusta Ministry of Health, Government of the Republic of Indonesia, Jakarta, Indonesia, 2011.
[26]
M. G. Weiss, “Stigma and the social burden of neglected tropical diseases,” PLoS Neglected Tropical Diseases, vol. 2, no. 5, article e237, 2008.
[27]
B. G. Link and J. C. Phelan, “Conceptualizing stigma,” Annual Review of Sociology, vol. 27, pp. 363–385, 2001.
[28]
G. Scambler, “Stigma and disease: changing paradigms,” The Lancet, vol. 352, no. 9133, pp. 1054–1055, 1998.
[29]
G. Joachim and S. Acorn, “Stigma of visible and invisible chronic conditions,” Journal of Advanced Nursing, vol. 32, no. 1, pp. 243–248, 2000.
[30]
P. W. Corrigan, F. E. Markowitz, and A. C. Watson, “Structural levels of mental illness stigma and discrimination,” Schizophrenia Bulletin, vol. 30, no. 3, pp. 481–491, 2004.
[31]
E. E. Jones, Social Stigma: The Psychology of Marked Relationships, WH Freeman, New York, NY, USA, 1984.
[32]
E. Goffman, Stigma: Notes on the Management of Spoiled Identity, Simon & Schuster, Inc., New York, NY, USA, 1963.
[33]
A. Jacoby, “Felt versus enacted stigma: a concept revisited. Evidence from a study of people with epilepsy in remission,” Social Science and Medicine, vol. 38, no. 2, pp. 269–274, 1994.
[34]
S. J. Yawalkar, Leprosy for Medical Practitioners and Paramedical Workers, Novartis Foundation for Sustainable Development, Basel, Switzerland, 2009.
[35]
M. Heijnders and S. van der Meij, “The fight against stigma: an overview of stigma-reduction strategies and interventions,” Psychology, Health & Medicine, vol. 11, no. 3, pp. 353–363, 2006.
[36]
H. Cross, M. Heijnders, and A. Dalal, “Interventions for stigma reduction—part 2: practical applications,” Disability, CBR & Inclusive Development, vol. 22, no. 3, pp. 71–80, 2012.
[37]
G. Thornicroft, E. Brohan, A. Kassam, and E. Lewis-Holmes, “Reducing stigma and discrimination: candidate interventions,” International Journal of Mental Health Systems, vol. 2, no. 1, article 3, 2008.
[38]
WHO, “Enhanced global strategy for further reducing the disease burden due to leprosy: 2011–2015,” Leprosy Review, vol. 80, no. 4, pp. 353–354, 2009.
[39]
M. K. Nations, G. V. Lira, and A. M. F. Catrib, “Stigma, deforming metaphors and patients' moral experience of multibacillary leprosy in sobral, Ceará State, Brazil,” Cadernos de Saude Publica, vol. 25, no. 6, pp. 1215–1224, 2009.
[40]
C. White, “Iatrogenic stigma in outpatient treatment for Hansen's disease (leprosy) in Brazil,” Health Education Research, vol. 23, no. 1, pp. 25–39, 2008.
[41]
L. A. el Hassan, E. A. G. Khalil, and A. M. el-Hassan, “Socio-cultural aspects of leprosy among the Masalit and Hawsa tribes in the Sudan,” Leprosy Review, vol. 73, no. 1, pp. 20–28, 2002.
[42]
J. Zou, Y. Yamanaka, M. John, M. Watt, J. Ostermann, and N. Thielman, “Religion and HIV in Tanzania: influence of religious beliefs on HIV stigma, disclosure, and treatment attitudes,” BMC Public Health, vol. 9, article 75, 2009.
[43]
S. Cotton, C. M. Puchalski, S. N. Sherman et al., “Spirituality and religion in patients with HIV/AIDS,” Journal of General Internal Medicine, vol. 21, supplement 5, pp. S5–S13, 2006.
[44]
M. G. Weiss, J. Ramakrishna, and D. Somma, “Health-related stigma: rethinking concepts and interventions,” Psychology, Health and Medicine, vol. 11, no. 3, pp. 277–287, 2006.
[45]
R. Yeo, “Disability, poverty and the new development agenda,” 2005.
[46]
WHO, “The world report on disability,” July 2011.
[47]
A. Kumar and M. Anbalagan, “Socio-economic experiences of leprosy patients,” Leprosy in India, vol. 55, no. 2, pp. 314–321, 1983.
[48]
S. Mitra, A. Posarac, and B. Vick, “Disability and poverty in developing countries: a multidimensional study,” World Development, vol. 41, pp. 1–18, 2013.
[49]
J. H. Calcraft, “An annotated bibliography on leprosy,” Asia Pacific Disability Rehabilitation Journal, vol. 17, no. 2, pp. 17–33, 2006.
[50]
H. Cross and R. Choudhary, “STEP: an intervention to address the issue of stigma related to leprosy in southern Nepal,” Leprosy Review, vol. 76, no. 4, pp. 316–324, 2005.
[51]
H. Cross and R. Choudhary, “Self care: a catalyst for community development,” Asia Pacific Disability Rehabilitation Journal, vol. 16, no. 2, pp. 100–114, 2005.
[52]
J. P. Ramirez, Squint: My Journey with Leprosy, University Press of Mississippi, 2009.
[53]
H. K. Nalaielua and S.-J. K.-A. Bowman, No Footprints in the Sand: A Memoir of Kalaupapa, Watermark Publishing, Honolulu, Hawaii, USA, 2006.
[54]
IDEA, Quest for Dignity: Personal Victories Over Leprosy/Hansen’s disease, The International Association for Integration, Dignity, and Economic Advancement.
